Comment on: Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis by Humby et al.

Clin Exp Rheumatol

Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey.

Published: September 2023

Download full-text PDF

Source
http://dx.doi.org/10.55563/clinexprheumatol/85mrazDOI Listing

Publication Analysis

Top Keywords

comment rituximab
4
rituximab versus
4
versus tocilizumab
4
tocilizumab anti-tnf
4
anti-tnf inadequate
4
inadequate responder
4
responder patients
4
patients rheumatoid
4
rheumatoid arthritis
4
arthritis humby
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!